Vitrolife AB

VTFN

Company Profile

  • Business description

    Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient’s fertility treatment, thereby enabling patients to receiveĀ support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The group has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.

  • Contact

    Box 9080
    Gothenburg400 92
    SWE

    T: +46 317218000

    https://www.vitrolife.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    1,151

Stocks News & Analysis

stocks

Will undervalued ASX share show progress in results?

Investors will get to see if the new strategy and capital management framework are working.
stocks

10 best US dividend aristocrats to buy now for 2026

These undervalued stocks with economic moats have increased their dividends for 25 consecutive years or more.
stocks

What to expect from the January Fed meeting

Central bankers are likely to hold interest rates steady, but Wall Street is focused on life after Powell.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,250.6050.70-0.55%
CAC 408,077.1175.71-0.93%
DAX 4024,819.9174.53-0.30%
Dow JONES (US)48,967.5835.83-0.07%
FTSE 10010,168.0839.72-0.39%
HKSE27,826.91699.962.58%
NASDAQ23,920.75103.650.44%
Nikkei 22553,358.7125.170.05%
NZX 50 Index13,412.8798.01-0.73%
S&P 5006,989.9511.350.16%
S&P/ASX 2008,933.9040.40-0.45%
SSE Composite Index4,151.2411.330.27%

Market Movers